Bispecific Therapies
Select for available bispecific therapies and steps to take when evaluating a patient.
This platform is intended to guide healthcare providers in the initial management of patients receiving immunotherapies such as bispecific T-cell engagers and CAR-T.
It does not replace clinical judgment, medical decision-making, or institutional policies.
Please contact the treating physician to establish a personalized plan of care.
